Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

Autor: Wright, EJ, Grund, B, Cysique, LA, Robertson, KR, Brew, BJ, Collins, G, Shlay, JC, Winston, A, Read, TRH, Price, RW, Initiatives, INS

Publikováno v: HIV medicine, vol 16 Suppl 1, iss S1
Wright, EJ; Grund, B; Cysique, LA; Robertson, KR; Brew, BJ; Collins, G; et al.(2015). Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV MEDICINE, 16, 97-108. doi: 10.1111/hiv.12238. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/6zb7b0nb

ObjectivesWe describe neuropsychological test performance (NP) in antiretroviral treatment (ART)-naïve HIV-positive individuals with CD4 cell counts above 500 cells/μL.MethodsIn a neurology substudy of the International Network for Strategic Initia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d948e6f3e9743b94afebbbdeeace1392
https://escholarship.org/uc/item/6zb7b0nb